MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

11.95 -0.17

Resumen

Variación precio

24h

Actual

Mínimo

11.93

Máximo

12.05

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+58.47% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.45%

Próximas Ganancias

9 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-139M

229M

Apertura anterior

12.12

Cierre anterior

11.95

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

154 / 349 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 abr 2026, 04:27 UTC

Noticias de Eventos Importantes

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

3 abr 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 abr 2026, 18:30 UTC

Noticias de Eventos Importantes

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3 abr 2026, 18:14 UTC

Charlas de Mercado

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3 abr 2026, 17:50 UTC

Charlas de Mercado

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3 abr 2026, 17:44 UTC

Adquisiciones, fusiones, absorciones

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3 abr 2026, 16:50 UTC

Noticias de Eventos Importantes

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3 abr 2026, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 abr 2026, 16:12 UTC

Ganancias

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3 abr 2026, 15:56 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3 abr 2026, 15:56 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Equities Roundup: Market Talk

3 abr 2026, 15:56 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

3 abr 2026, 15:20 UTC

Noticias de Eventos Importantes

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3 abr 2026, 15:08 UTC

Adquisiciones, fusiones, absorciones

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3 abr 2026, 14:11 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3 abr 2026, 12:56 UTC

Charlas de Mercado

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3 abr 2026, 08:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 abr 2026, 08:01 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 abr 2026, 08:01 UTC

Charlas de Mercado

Meituan's Profitability Likely to Improve This Year -- Market Talk

3 abr 2026, 07:45 UTC

Charlas de Mercado

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3 abr 2026, 06:17 UTC

Charlas de Mercado

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3 abr 2026, 06:17 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 abr 2026, 04:33 UTC

Charlas de Mercado

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3 abr 2026, 04:33 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 abr 2026, 04:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

3 abr 2026, 04:01 UTC

Charlas de Mercado

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

3 abr 2026, 02:01 UTC

Charlas de Mercado

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

3 abr 2026, 01:59 UTC

Charlas de Mercado

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

3 abr 2026, 01:44 UTC

Charlas de Mercado

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

3 abr 2026, 01:22 UTC

Charlas de Mercado

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

58.47% repunte

Estimación a 12 Meses

Media 19 USD  58.47%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

154 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat